NCT05507502 - Timing of Influenza Vaccination in Patients With Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions

Heart Failure

Interventions

BIOLOGICAL

Influenza vaccination administration

There will be approximately 40 participants who consent; they will be randomized in a 1:1 manner to receiving the influenza vaccination during their heart failure hospitalization versus receiving the vaccine during their first follow-up in the heart failure clinic.

Trial Locations (1)

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal